Clinical trials are essential for bringing new treatments to patients, but they’re not without challenges. Recruiting the right participants, staying on budget, and avoiding delays are some of the biggest hurdles. Unfortunately, traditional methods of finding and enrolling patients often fall short—costing time, money, and sometimes even the success of the trial.
That’s where precision patient finding comes in. By using tools like genomic profiling and AI, this approach is making trials faster, more efficient, and ultimately more patient-friendly.
Finding participants for clinical trials has always been tough, and it gets even harder when specific genetic criteria are involved. And even after identifying eligible participants, many trials still face delays due to insufficient enrollment or high dropout rates.
Delays are another major challenge. Studies show the average trial is delayed by over 12 months, with daily costs ranging from $7,829 for Phase I trials to $55,716 for Phase III trials. These setbacks don’t just inflate budgets—they also slow the delivery of potentially life-saving treatments to patients.
Precision patient finding offers a smarter, more efficient approach to recruitment. Instead of running separate genetic tests for each trial, technologies like comprehensive genome profiling (CGP) can test for multiple biomarkers at once. Beyond cost savings, these types of methods accelerate recruitment, enabling sponsors to complete enrollment faster and reduce trial delays.
AI also makes the process easier by analyzing large datasets to identify potential participants more efficiently. By integrating genomic data with real-world evidence, AI helps sponsors target recruitment efforts to sites with high concentrations of eligible patients, making it easier to meet enrollment goals and avoid delays caused by underperforming trial sites.
Precision patient finding doesn’t just improve recruitment, it also helps retain participants by ensuring they are a good fit for the study. By using tools to identify individuals who are more likely to complete the trial, sponsors can minimize dropout rates, which can cost over $6,500 per participant to replace.
Additionally, precision approaches lead to better patient experiences. By focusing on highly relevant participants, trials can offer a more personalized experience, reducing the burden on patients and building trust in the clinical research process.
Precision patient finding is making clinical trials smarter, faster, and more effective. By cutting costs, reducing delays, and improving patient experiences, this approach is helping researchers focus on what really matters: delivering new treatments to the people who need them most.
Want to learn more about how precision patient finding works? Download our whitepaper to see how it’s transforming clinical research.